CIK 0001682639 · Non-accelerated filer<br>Smaller reporting company
HYPERION DEFI, INC.
Sign in to watch- Ticker
- HYPD
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471178401
- Phone
- 833-393-6684
- Business address
- 3090 NOWITZKI WAY, SUITE 300, DALLAS, TX, 75219
- Former names
- EYENOVIA, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-30 | Grant Stuart M. 10% owner | Purchase | +17,940 | $3.70 | $66K | 2,244,123 |
| 2019-09-27 | Grant Stuart M. 10% owner | Purchase | +312 | $4.00 | $1K | 2,226,183 |
| 2019-08-16 | ESHELMAN FREDRIC N Director | Grant or award | +8,038 | 1,285,499 | ||
| 2019-08-16 | ESHELMAN FREDRIC N Director | Grant or award · Stock Option (right to buy) | +9,057 | 9,057 | ||
| 2019-08-16 | MATHER CHARLES E IV Director | Grant or award | +8,038 | 16,071 | ||
| 2019-08-16 | MATHER CHARLES E IV Director | Grant or award · Stock Option (right to buy) | +9,057 | 9,057 | ||
| 2019-08-16 | SUN ANTHONY Y Director | Grant or award | +8,038 | 12,071 | ||
| 2019-08-16 | SUN ANTHONY Y Director | Grant or award · Stock Option (right to buy) | +9,057 | 9,057 | ||
| 2019-08-16 | LEE KENNETH B JR Director | Grant or award | +8,038 | 12,071 | ||
| 2019-08-16 | LEE KENNETH B JR Director | Grant or award · Stock Option (right to buy) | +9,057 | 9,057 | ||
| 2019-08-16 | MARIO ERNEST Director | Grant or award | +8,038 | 280,779 | ||
| 2019-08-16 | MARIO ERNEST Director | Grant or award · Stock Option (right to buy) | +9,057 | 9,057 | ||
| 2019-08-16 | LaBelle Curt H Director | Grant or award · Stock Option (right to buy) | +45,256 | 45,256 | ||
| 2019-08-16 | Rowe Michael M Vice President of Marketing | Grant or award · Stock Option (right to buy) | +42,722 | 42,722 | ||
| 2019-08-16 | Clasby Jennifer G VP, Clinical Operations | Grant or award · Stock Option (right to buy) | +42,722 | 42,722 | ||
| 2019-08-16 | Clauson Luke VP, R&D and Manufacturing | Grant or award · Stock Option (right to buy) | +42,722 | 42,722 | ||
| 2019-08-16 | GANDOLFO JOHN P Chief Financial Officer | Grant or award · Stock Option (right to buy) | +53,402 | 53,402 | ||
| 2019-08-16 | Ianchulev Tsontcho Chief Executive Officer | Grant or award · Stock Option (right to buy) | +183,703 | 183,703 | ||
| 2019-07-11 | MARIO ERNEST Director | Purchase | +35,971 | $2.78 | $100K | 272,741 |
| 2019-07-11 | LaBelle Curt H Director | Purchase | +17,985 | $2.78 | $50K | 27,985 |
Page 14 of 16 · 317 trades